Seven Eight Capital, LP Spring Works Therapeutics, Inc. Transaction History
Seven Eight Capital, LP
- $1.05 Billion
- Q3 2024
A detailed history of Seven Eight Capital, LP transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Seven Eight Capital, LP holds 56,777 shares of SWTX stock, worth $2.02 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
56,777
Previous 49,224
15.34%
Holding current value
$2.02 Million
Previous $1.85 Million
1.89%
% of portfolio
0.17%
Previous 0.2%
Shares
3 transactions
Others Institutions Holding SWTX
# of Institutions
237Shares Held
68.9MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$239 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$200 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$137 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$125 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$122 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.22B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...